OPICAPONE AS FIRST-LINE ADJUNCTIVE LEVODOPA TREATMENT IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS: BIPARK-I AND II COMBINED POST-HOC ANALYSIS

被引:0
|
作者
Ferreira, J. J. [1 ]
Poewe, W. [2 ]
Antonini, A. [3 ]
Gama, H. [4 ]
Rocha, J. F. [4 ]
Magalhaes, D. [4 ,5 ]
Soares-da-Silva, P. [5 ,6 ,7 ]
机构
[1] Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal
[2] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] BIAL Portela & Ca SA, Med Affairs Dept, Coronado, Portugal
[5] Univ Porto, Porto, Portugal
[6] BIAL Portela & Ca SA, Dept Res & Dev, Coronado, Portugal
[7] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 214
引用
收藏
页码:E63 / E63
页数:1
相关论文
共 50 条
  • [1] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 189 - 190
  • [2] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S447 - S448
  • [3] Efficacy of Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: a Post-Hoc Analysis from Double-Blind Combined BIPARK-I and II Data
    Hauser, Robert
    Ferreira, Joaquim J.
    Poewe, Werner
    Antonini, Angelo
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    Klepitskaya, Olga
    Liang, Grace
    NEUROLOGY, 2020, 94 (15)
  • [4] Opicapone's added benefit as a first-line adjunctive therapy to levodopa and when used promptly in the motor fluctuations spectrum of Parkinson's disease: a post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Ferreira, J.
    Antonini, A.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S445 - S445
  • [5] Super-Responders to Opicapone Adjunct Treatment to Levodopa in Parkinson's Disease Patients with Motor Fluctuations: Combined Post-Hoc Analysis of BIPARK-I and II
    Antonini, A.
    Poewe, W.
    Ferreira, J.
    Ebersbach, G.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S436 - S436
  • [6] Super-responders to opicapone adjunct treatment to levodopa in parkinson's disease patients with motor fluctuations: combined post-hoc analysis of BIPARK-I and II
    Antonini, A.
    Poewe, W.
    Ferreira, J. J.
    Ebersbach, G.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 631 - 632
  • [7] Efficacy and Safety of Opicapone in Parkinson's Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S444 - S444
  • [8] EFFICACY/SAFETY OF OPICAPONE IN PARKINSON'S DISEASE PATIENTS ACCORDING TO DURATION OF MOTOR FLUCTUATIONS: POST-HOC ANALYSIS OF BIPARK-I AND II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E63 - E64
  • [9] Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 659 - 660
  • [10] Efficacy of Opicapone in Patients with Parkinson's Disease with Levodopa Dose Reduction: a Pooled Post-Hoc Analysis of BIPARK-I and II
    Rascol, O.
    Poewe, W.
    Ferreira, J. J.
    Lees, A.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1105 - 1106